Skip to content
10-Q

Quarterly Report

bluebird bio, Inc.

0001293971-25-000014

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 9.79M sh
Shares Diluted Q1 2025 · Mar 31, 2025 9.75M sh
Shares Diluted restated Q1 2025 · Mar 31, 2024 9.66M sh
Capex Q1 2025 · Mar 31, 2025 $859K
Capex Q1 2025 · Mar 31, 2024 $1.78M
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$43.44M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$74.68M
Short Term Debt Q1 2025 · Mar 31, 2025 $72.47M
Short Term Debt Q1 2025 · Dec 31, 2024 $71.51M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $78.74M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $62.31M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $212.05M
Stockholders Equity Q1 2025 · Mar 31, 2025 −$57.87M
Stockholders Equity Q1 2025 · Dec 31, 2024 −$31.53M
Stockholders Equity Q1 2025 · Mar 31, 2024 $131.05M
Stockholders Equity Q1 2025 · Dec 31, 2023 $194.54M
Current Liabilities Q1 2025 · Mar 31, 2025 $315.08M
Current Liabilities Q1 2025 · Dec 31, 2024 $321.46M
Total Liabilities Q1 2025 · Mar 31, 2025 $353.82M
Total Liabilities Q1 2025 · Dec 31, 2024 $491.77M
Current Assets Q1 2025 · Mar 31, 2025 $174.52M
Current Assets Q1 2025 · Dec 31, 2024 $154.67M
Total Assets Q1 2025 · Mar 31, 2025 $295.96M
Total Assets Q1 2025 · Dec 31, 2024 $460.23M
Eps Diluted Q1 2025 · Mar 31, 2025 −$2.98
Eps Diluted restated Q1 2025 · Mar 31, 2024 −$7.23
Eps Basic Q1 2025 · Mar 31, 2025 −$2.98
Eps Basic restated Q1 2025 · Mar 31, 2024 −$7.23
Sga Expense Q1 2025 · Mar 31, 2025 $30.26M
Sga Expense Q1 2025 · Mar 31, 2024 $46.33M
Rd Expense Q1 2025 · Mar 31, 2025 $17.72M
Rd Expense Q1 2025 · Mar 31, 2024 $25.07M
Net Income Q1 2025 · Mar 31, 2025 −$29.07M
Net Income Q1 2025 · Mar 31, 2024 −$69.8M
Operating Income Q1 2025 · Mar 31, 2025 −$24.61M
Operating Income Q1 2025 · Mar 31, 2024 −$78.69M
Gross Profit Q1 2025 · Mar 31, 2025 $26.48M
Gross Profit Q1 2025 · Mar 31, 2024 −$7.29M
Cost Of Revenue Q1 2025 · Mar 31, 2025 $12.24M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $25.86M
Revenue Q1 2025 · Mar 31, 2025 $38.71M
Revenue Q1 2025 · Mar 31, 2024 $18.56M